ClinicalTrials.gg
Active, not recruitingNCT06006962AgeWISE-APUpdated Jun 12, 2026

Aging Well Through Interactions and Scientific Education - Action Plan (AgeWISE-AP)

An interventional study of Aging Well through Interactions and Scientific Education - Action Plan in Cognitive Aging, sponsored by VA Office of Research and Development. Active, not recruiting at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-12.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
134
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The purpose of this study is to learn about the effects of AgeWISE-Action Plan (AgeWISE-AP), a 20-week program designed to provide education and individualized planning with a goal of improving brain health.

Read the detailed description

The overall goal of this proposal is to conduct a fully powered randomized controlled trial of a multi-component intervention designed to provide education about brain aging, improve feelings of control over brain aging, and deliver practical assistance with creation of an executable action plan (AgeWISE-Action Plan). The AgeWISE-Action Plan (AgeWISE-AP) is intended to extend our prior AgeWISE program by adding an individualized action plan component to increase older Veteran engagement in brain healthy lifestyle activities.

AIM 1 (primary): To determine whether AgeWISE-AP increases older Veterans' engagement in lifestyle factors that promote brain health. AgeWISE provides information about the differences between normal and diseased brain aging and lifestyle factors that contribute to brain health. The action plan (AP) component will use this foundation to collaboratively create an individualized brain health plan to increase Veteran engagement in brain healthy lifestyle activities. H1. AgeWISE-AP participants will demonstrate increased engagement in brain-healthy lifestyle activities compared to the control group.

AIM 2 (primary): To determine whether AgeWISE-AP improves psychological wellness. AgeWISE provides information about the relationship between cognitive aging and affective states (e.g., depression) and attitudes about aging, and teaches stress reduction techniques. The action plan (AP) will provide additional individualized supports to improve psychological well-being with personalized goals and lifestyle modifications (e.g., diet, exercise, sleep, cognitive stimulation). H2. AgeWISE-AP participants will show increases in perception of control over cognitive aging, meaning and purpose in life, quality of life, and self-efficacy, as well as improved attitudes toward aging and decreased loneliness, depression, and anxiety compared to the control group.

AIM 3 (primary): To determine whether AgeWISE-AP improves cognition. Cognitive strategies to improve cognition and functioning are presented and practiced over three AgeWISE sessions, with homework to improve generalization to day-to-day life. Engagement in brain-healthy lifestyle activities will be accomplished through the action plan (AP). H3. Self-reported memory contentment, ability, and compensatory strategy use will increase and objective cognitive testing will be better for AgeWISE-AP participants compared to the control group.

Aim 4 (exploratory): To determine whether AgeWISE-AP influences biomarkers of brain health using structural neuroimaging methods. H4. At one-year follow-up AgeWISE-AP participants will have less volumetric decline in dementia-related brain regions compared to the control group.

02

Conditions studied

  • Cognitive Aging

Keywords

  • Cognitive Aging
  • Lifestyle Risk Reduction
03

In context

Risk Reduction Behavior

291 studies on the registry are indexed under Risk Reduction Behavior; 39 are open to participants now.

This study's enrollment of 134 is below the median of 201 across 250 interventional studies indexed under Risk Reduction Behavior.

Browse Risk Reduction Behavior studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,771 studies on the registry; 392 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veterans > 60 years old with concerns about brain aging who want to learn more about cognitive aging
  • English speaking as all intervention materials are written in English

Exclusion criteria

Exclusion Criteria:

  • Veterans with impairment on a cognitive screening measure, as determined using a cutoff score for dementia of \<24 OR self or other reported diagnosis of a brain disorder affecting cognition such as Alzheimer's disease, Parkinson's disease, other dementia, major stroke, or brain injury or diagnosis of psychotic disorder such as schizophrenia
  • Active alcohol or substance abuse
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
134 participants (actual)

Study arms

  • Experimental
    Intervention

    Receiving intervention - AgeWISE-AP

    Other: Aging Well through Interactions and Scientific Education - Action Plan

  • No intervention
    Waitlist Control

    No intervention; will be invited to participate in intervention after completion of study.

Interventions

  • OtherAging Well through Interactions and Scientific Education - Action Plan

    20-week program designed to provide education and individualized planning with a goal of improving brain health.

    Also known as: AgeWISE-AP

06

What researchers measure

Primary outcomes

  1. Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS)

    Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS) is a 41-item scale that explores the frequency and duration of light, moderate, and vigorous physical activities assessed using weekly frequency and duration.

    Time frame: Baseline

  2. Cognitive Health Questionnaire (CHQ)

    17-item scale that assesses frequency of various lifestyle factors, including nutritional variables and use of cognitive strategies in daily life.

    Time frame: Baseline

  3. Health-Promoting Lifestyle Profile II (HPLP II)

    A 52-item questionnaire composed of six subscales including health responsibility, nutrition, physical activity, stress management, interpersonal relations, and spiritual growth. Response options are provided on a 4-point Likert scale. Subscale scores are calculated by obtaining a mean score with higher scores indicating, better outcomes.

    Time frame: Baseline

  4. PROMIS Social Roles and Activities

    8 items assessing satisfaction with performing one's usual social roles and activities with response options provided on a 5-point Likert scale. A higher score represents better ability to participate or more satisfaction.

    Time frame: Baseline

  5. Global Sleep Assessment Questionnaire (GSAQ)

    11 items covering mood, life activities, and medical issues as they relate to sleep and symptoms associated with disorders of sleep. Response options are provided on a 4-point Likert scale with lower scores indicating better outcomes.

    Time frame: Baseline

  6. General and Memory Specific Control Beliefs Scale

    Used to measure perceived control over cognitive health. The scale is composed of two sets of items focusing on general and memory-specific control beliefs. We are interested in examining changes in memory-specific control beliefs, which include 4 items with 3 answer choices.

    Time frame: Baseline

  7. Philadelphia Geriatric Center Morale Scale (PGCMS)

    17 item scale measuring dimensions of emotional adjustments in persons aged 70 to 90. It provides a multidimensional approach to assessing the state of psychological wellbeing and perceived morale using three factors: agitation, attitude toward own aging and lonely satisfaction. Total score ranges from 0-17 with higher scores indicating higher morality.

    Time frame: Baseline

  8. The NIH Toolbox Meaning and Purpose Short Form

    8-item, form that assesses the degree to which participants feel their lives matter/make sense. Each item is rated on a 5-point Likert scale with responses ranging from "strongly disagree" to "strongly agree" and from "not at all" to "very much." Total score ranges from 8-40 with higher scores indicating better outcomes.

    Time frame: Baseline

  9. The Patient Health Questionnaire-9 (PHQ-9)

    Reliable and valid (in a variety of patient populations) multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. Response options are provided on a 4-point Likert scale, with total score ranging from 1-27. Lower scores indicate better outcomes.

    Time frame: Baseline

  10. The Center for Epidemiological Studies-Depression (CES-D)

    20-item measure that rates how often over the past week respondents have experienced depressive symptoms. Response options are provided on a 4-point Likert scale with total scores ranging from 0-60. Lower scores indicate lower depressive symptoms.

    Time frame: Baseline

  11. The State-Trait Anxiety Inventory (STAI)

    Commonly used measure of anxiety with 40 total items. Response options are provided on a 4-point Likert scale. Total score range from 40-160 with lower scores indicating lower anxiety.

    Time frame: Baseline

  12. The General Self-Efficacy Scale (GSE)

    10-item psychometric scale that assesses optimistic self-beliefs to cope with a variety of difficult demands in life. Response options are provided on a 4-point Likert scale with total score ranging from 10-40. Higher total score indicates better outcomes.

    Time frame: Baseline

  13. Multifactorial Memory Questionnaire (MMQ)

    A measure constructed to reflect aspects of memory that are potentially amenable to clinical intervention. The Contentment subscale contains 18 statements that assess emotions and perceptions about current memory ability including anxiety, embarrassment, and irritability. The Ability subscale contains 20 items phrased as memory failures in everyday memory situations (e.g., forgetting an appointment). The Strategy subscale measures self-reported cognitive strategy use. Response options are provided on a 5-point Likert scale. Total score ranges from 0-80 with higher scores indicating better outcomes.

    Time frame: Baseline

  14. The Montreal Cognitive Assessment (MoCA)

    Screening instrument that assesses multiple cognitive domains with total score ranging from 0 to 30 points, and a cut score of 24 has demonstrated very good specificity (by correctly identifying 87% of healthy participants) and excellent sensitivity when differentiating MCI (90%) and Alzheimer disease (100%) from healthy comparisons. Total score ranges from 0-30 with higher score indicating better outcomes.

    Time frame: Baseline

  15. Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS)

    Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS) is a 41-item scale that explores the frequency and duration of light, moderate, and vigorous physical activities assessed using weekly frequency and duration.

    Time frame: 4-months

  16. Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS)

    Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS) is a 41-item scale that explores the frequency and duration of light, moderate, and vigorous physical activities assessed using weekly frequency and duration.

    Time frame: 8-months

  17. Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS)

    Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS) is a 41-item scale that explores the frequency and duration of light, moderate, and vigorous physical activities assessed using weekly frequency and duration.

    Time frame: 12-months

  18. Cognitive Health Questionnaire (CHQ)

    17-item scale that assesses frequency of various lifestyle factors, including nutritional variables and use of cognitive strategies in daily life.

    Time frame: 4-months

  19. Cognitive Health Questionnaire (CHQ)

    17-item scale that assesses frequency of various lifestyle factors, including nutritional variables and use of cognitive strategies in daily life.

    Time frame: 8-months

  20. Cognitive Health Questionnaire (CHQ)

    17-item scale that assesses frequency of various lifestyle factors, including nutritional variables and use of cognitive strategies in daily life.

    Time frame: 12-months

  21. Health-Promoting Lifestyle Profile II (HPLP II)

    A 52-item questionnaire composed of six subscales including health responsibility, nutrition, physical activity, stress management, interpersonal relations, and spiritual growth. Response options are provided on a 4-point Likert scale. Subscale scores are calculated by obtaining a mean score with higher scores indicating, better outcomes.

    Time frame: 4-months

  22. Health-Promoting Lifestyle Profile II (HPLP II)

    A 52-item questionnaire composed of six subscales including health responsibility, nutrition, physical activity, stress management, interpersonal relations, and spiritual growth. Response options are provided on a 4-point Likert scale. Subscale scores are calculated by obtaining a mean score with higher scores indicating, better outcomes.

    Time frame: 8-months

  23. Health-Promoting Lifestyle Profile II (HPLP II)

    A 52-item questionnaire composed of six subscales including health responsibility, nutrition, physical activity, stress management, interpersonal relations, and spiritual growth. Response options are provided on a 4-point Likert scale. Subscale scores are calculated by obtaining a mean score with higher scores indicating, better outcomes.

    Time frame: 12-months

  24. PROMIS Social Roles and Activities

    8 items assessing satisfaction with performing one's usual social roles and activities with response options provided on a 5-point Likert scale. A higher score represents better ability to participate or more satisfaction.

    Time frame: 4-months

  25. PROMIS Social Roles and Activities

    8 items assessing satisfaction with performing one's usual social roles and activities with response options provided on a 5-point Likert scale. A higher score represents better ability to participate or more satisfaction.

    Time frame: 8-months

  26. PROMIS Social Roles and Activities

    8 items assessing satisfaction with performing one's usual social roles and activities with response options provided on a 5-point Likert scale. A higher score represents better ability to participate or more satisfaction.

    Time frame: 12-months

  27. Global Sleep Assessment Questionnaire (GSAQ)

    11 items covering mood, life activities, and medical issues as they relate to sleep and symptoms associated with disorders of sleep. Response options are provided on a 4-point Likert scale with lower scores indicating better outcomes.

    Time frame: 4-months

  28. Global Sleep Assessment Questionnaire (GSAQ)

    11 items covering mood, life activities, and medical issues as they relate to sleep and symptoms associated with disorders of sleep. Response options are provided on a 4-point Likert scale with lower scores indicating better outcomes.

    Time frame: 8-months

  29. Global Sleep Assessment Questionnaire (GSAQ)

    11 items covering mood, life activities, and medical issues as they relate to sleep and symptoms associated with disorders of sleep. Response options are provided on a 4-point Likert scale with lower scores indicating better outcomes.

    Time frame: 12-months

  30. General and Memory Specific Control Beliefs Scale

    Used to measure perceived control over cognitive health. The scale is composed of two sets of items focusing on general and memory-specific control beliefs. We are interested in examining changes in memory-specific control beliefs, which include 4 items with 3 answer choices.

    Time frame: 4-months

  31. General and Memory Specific Control Beliefs Scale

    Used to measure perceived control over cognitive health. The scale is composed of two sets of items focusing on general and memory-specific control beliefs. We are interested in examining changes in memory-specific control beliefs, which include 4 items with 3 answer choices.

    Time frame: 8-months

  32. General and Memory Specific Control Beliefs Scale

    Used to measure perceived control over cognitive health. The scale is composed of two sets of items focusing on general and memory-specific control beliefs. We are interested in examining changes in memory-specific control beliefs, which include 4 items with 3 answer choices.

    Time frame: 12-months

  33. Philadelphia Geriatric Center Morale Scale (PGCMS)

    17 item scale measuring dimensions of emotional adjustments in persons aged 70 to 90. It provides a multidimensional approach to assessing the state of psychological wellbeing and perceived morale using three factors: agitation, attitude toward own aging and lonely satisfaction. Total score ranges from 0-17 with higher scores indicating higher morality.

    Time frame: 4-months

  34. Philadelphia Geriatric Center Morale Scale (PGCMS)

    17 item scale measuring dimensions of emotional adjustments in persons aged 70 to 90. It provides a multidimensional approach to assessing the state of psychological wellbeing and perceived morale using three factors: agitation, attitude toward own aging and lonely satisfaction. Total score ranges from 0-17 with higher scores indicating higher morality.

    Time frame: 8-months

  35. Philadelphia Geriatric Center Morale Scale (PGCMS)

    17 item scale measuring dimensions of emotional adjustments in persons aged 70 to 90. It provides a multidimensional approach to assessing the state of psychological wellbeing and perceived morale using three factors: agitation, attitude toward own aging and lonely satisfaction. Total score ranges from 0-17 with higher scores indicating higher morality.

    Time frame: 12-months

  36. The NIH Toolbox Meaning and Purpose Short Form

    8-item, form that assesses the degree to which participants feel their lives matter/make sense. Each item is rated on a 5-point Likert scale with responses ranging from "strongly disagree" to "strongly agree" and from "not at all" to "very much." Total score ranges from 8-40 with higher scores indicating better outcomes.

    Time frame: 4-months

  37. The NIH Toolbox Meaning and Purpose Short Form

    8-item, form that assesses the degree to which participants feel their lives matter/make sense. Each item is rated on a 5-point Likert scale with responses ranging from "strongly disagree" to "strongly agree" and from "not at all" to "very much." Total score ranges from 8-40 with higher scores indicating better outcomes.

    Time frame: 8-months

  38. The NIH Toolbox Meaning and Purpose Short Form

    8-item, form that assesses the degree to which participants feel their lives matter/make sense. Each item is rated on a 5-point Likert scale with responses ranging from "strongly disagree" to "strongly agree" and from "not at all" to "very much." Total score ranges from 8-40 with higher scores indicating better outcomes.

    Time frame: 12-months

  39. The Patient Health Questionnaire-9 (PHQ-9)

    Reliable and valid (in a variety of patient populations) multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. Response options are provided on a 4-point Likert scale, with total score ranging from 1-27. Lower scores indicate better outcomes.

    Time frame: 4-months

  40. The Patient Health Questionnaire-9 (PHQ-9)

    Reliable and valid (in a variety of patient populations) multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. Response options are provided on a 4-point Likert scale, with total score ranging from 1-27. Lower scores indicate better outcomes.

    Time frame: 8-months

  41. The Patient Health Questionnaire-9 (PHQ-9)

    Reliable and valid (in a variety of patient populations) multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. Response options are provided on a 4-point Likert scale, with total score ranging from 1-27. Lower scores indicate better outcomes.

    Time frame: 12-months

  42. The Center for Epidemiological Studies-Depression (CES-D)

    20-item measure that rates how often over the past week respondents have experienced depressive symptoms. Response options are provided on a 4-point Likert scale with total scores ranging from 0-60. Lower scores indicate lower depressive symptoms.

    Time frame: 4-months

  43. The Center for Epidemiological Studies-Depression (CES-D)

    20-item measure that rates how often over the past week respondents have experienced depressive symptoms. Response options are provided on a 4-point Likert scale with total scores ranging from 0-60. Lower scores indicate lower depressive symptoms.

    Time frame: 8-months

  44. The Center for Epidemiological Studies-Depression (CES-D)

    20-item measure that rates how often over the past week respondents have experienced depressive symptoms. Response options are provided on a 4-point Likert scale with total scores ranging from 0-60. Lower scores indicate lower depressive symptoms.

    Time frame: 12-months

  45. The State-Trait Anxiety Inventory (STAI)

    Commonly used measure of anxiety with 40 total items. Response options are provided on a 4-point Likert scale. Total score range from 40-160 with lower scores indicating lower anxiety.

    Time frame: 4-months

  46. The State-Trait Anxiety Inventory (STAI)

    Commonly used measure of anxiety with 40 total items. Response options are provided on a 4-point Likert scale. Total score range from 40-160 with lower scores indicating lower anxiety.

    Time frame: 8-months

  47. The State-Trait Anxiety Inventory (STAI)

    Commonly used measure of anxiety with 40 total items. Response options are provided on a 4-point Likert scale. Total score range from 40-160 with lower scores indicating lower anxiety.

    Time frame: 12-months

  48. The General Self-Efficacy Scale (GSE)

    10-item psychometric scale that assesses optimistic self-beliefs to cope with a variety of difficult demands in life. Response options are provided on a 4-point Likert scale with total score ranging from 10-40. Higher total score indicates better outcomes.

    Time frame: 4-months

  49. The General Self-Efficacy Scale (GSE)

    10-item psychometric scale that assesses optimistic self-beliefs to cope with a variety of difficult demands in life. Response options are provided on a 4-point Likert scale with total score ranging from 10-40. Higher total score indicates better outcomes.

    Time frame: 8-months

  50. The General Self-Efficacy Scale (GSE)

    10-item psychometric scale that assesses optimistic self-beliefs to cope with a variety of difficult demands in life. Response options are provided on a 4-point Likert scale with total score ranging from 10-40. Higher total score indicates better outcomes.

    Time frame: 12-months

  51. Multifactorial Memory Questionnaire (MMQ)

    A measure constructed to reflect aspects of memory that are potentially amenable to clinical intervention. The Contentment subscale contains 18 statements that assess emotions and perceptions about current memory ability including anxiety, embarrassment, and irritability. The Ability subscale contains 20 items phrased as memory failures in everyday memory situations (e.g., forgetting an appointment). The Strategy subscale measures self-reported cognitive strategy use. Response options are provided on a 5-point Likert scale. Total score ranges from 0-80 with higher scores indicating better outcomes.

    Time frame: 4-months

  52. Multifactorial Memory Questionnaire (MMQ)

    A measure constructed to reflect aspects of memory that are potentially amenable to clinical intervention. The Contentment subscale contains 18 statements that assess emotions and perceptions about current memory ability including anxiety, embarrassment, and irritability. The Ability subscale contains 20 items phrased as memory failures in everyday memory situations (e.g., forgetting an appointment). The Strategy subscale measures self-reported cognitive strategy use. Response options are provided on a 5-point Likert scale. Total score ranges from 0-80 with higher scores indicating better outcomes.

    Time frame: 8-months

  53. Multifactorial Memory Questionnaire (MMQ)

    A measure constructed to reflect aspects of memory that are potentially amenable to clinical intervention. The Contentment subscale contains 18 statements that assess emotions and perceptions about current memory ability including anxiety, embarrassment, and irritability. The Ability subscale contains 20 items phrased as memory failures in everyday memory situations (e.g., forgetting an appointment). The Strategy subscale measures self-reported cognitive strategy use. Response options are provided on a 5-point Likert scale. Total score ranges from 0-80 with higher scores indicating better outcomes.

    Time frame: 12-months

  54. The Montreal Cognitive Assessment (MoCA)

    Screening instrument that assesses multiple cognitive domains with total score ranging from 0 to 30 points, and a cut score of 24 has demonstrated very good specificity (by correctly identifying 87% of healthy participants) and excellent sensitivity when differentiating MCI (90%) and Alzheimer disease (100%) from healthy comparisons. Total score ranges from 0-30 with higher score indicating better outcomes.

    Time frame: 4-months

  55. The Montreal Cognitive Assessment (MoCA)

    Screening instrument that assesses multiple cognitive domains with total score ranging from 0 to 30 points, and a cut score of 24 has demonstrated very good specificity (by correctly identifying 87% of healthy participants) and excellent sensitivity when differentiating MCI (90%) and Alzheimer disease (100%) from healthy comparisons. Total score ranges from 0-30 with higher score indicating better outcomes.

    Time frame: 8-months

  56. The Montreal Cognitive Assessment (MoCA)

    Screening instrument that assesses multiple cognitive domains with total score ranging from 0 to 30 points, and a cut score of 24 has demonstrated very good specificity (by correctly identifying 87% of healthy participants) and excellent sensitivity when differentiating MCI (90%) and Alzheimer disease (100%) from healthy comparisons. Total score ranges from 0-30 with higher score indicating better outcomes.

    Time frame: 12-months

07

Study locations

1 site
08

References and documents

Publications

  • O'Connor MK, Szemko J, McLaren JE, Moo LR, Metcalf EE, Nguyen A, Kraft ML, Frank B, Salat D, Randolph JJ, Tripodis Y. A 20-week, randomized controlled trial to determine the efficacy of the Aging Well through Interaction and Scientific Education - Action Plan (AgeWISE-AP) program in older Veterans. BMC Geriatr. 2025 Aug 4;25(1):588. doi: 10.1186/s12877-025-06207-x. PubMed 40760411 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06006962
Collaborators
VA Boston Healthcare System
Responsible party
Sponsor
First posted
Aug 23, 2023
Start date
Jan 1, 2024
Primary completion
May 31, 2026
Completion
Dec 31, 2027 (estimated)
Last update
Jun 12, 2026

Study contacts

Maureen O'Connor, PsyD
principal investigator · VA Bedford HealthCare System, Bedford, MA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion